HLA polymorphisms and risk of glioblastoma in Koreans.

PURPOSE

Immune responses for cancer cells can be altered according to genetic variation of human leukocyte antigen (HLA). Association of HLA polymorphism with risk of various cancer types is well known. However, the association between HLA and glioblastoma (GBM) remains uncertain. We sought to evaluate the association of HLA polymorphism with risk of GBM development in Koreans.

MATERIALS AND METHODS

A case-control study was performed to identify the odds ratios (OR) of HLA class I and II genes for GBM. The control group consisted of 142 healthy Korean volunteers, and the GBM group was 80 patients with newly diagnosed GBM at our institution. HLA class I (-A, -B, and-C) and class II (-DR, -DQ, and-DP) genotyping was performed by high-resolution polymerase chain reaction (PCR)-sequence-based typing (PCR-SBT) methods.

RESULTS

There were significantly decreased frequencies of HLA-A26:02 (OR 0.22 CI 0.05-0.98), HLA-C08:01 (OR 0.29 CI 0.10-0.87), and HLA-DRB108:03 (OR 0.32 CI 0.11-0.98), while there was significantly increased frequency of HLA-C04:01 (OR 2.29 CI 1.05-4.97). In analysis of haplotypes, the frequency of DRB114:05-DQB105:03 was significantly decreased (OR 0.22 CI 0.05-0.98).

CONCLUSION

This study suggests that genetic variations of HLA may affect GBM development in Koreans. Further investigations with larger sample sizes are needed to delineate any potential role of the HLA polymorphisms in the pathogenesis of GBM development.